China Banned the use of Cannabis-derived Ingredients in Cosmetic Products
Cannabis-derived ingredients, especially CBD, are popular compounds in the beauty industry. Despite being one of the world’s largest producers of hemp, China has mandated a ban on some cannabis-derived ingredients in cosmetic products, while its neighbouring countries are doing the opposite.

CHINA – ONE OF THE WORLD LARGEST PRODUCER OF HEMP

Since 1985, marijuana is classified in China as a dangerous narcotic and the possession of hemp seeds is illegal. Nevertheless, China represents one of the world’s largest producer of hemp (a strain of Cannabis sativa) but most of it has exportation as its final destination. Hemp production is allowed in the provinces of Yunnan, Heilongjiang and Jilin, representing in 2019 about half of the world’s hemp resources (3 regions together), according to the US Foreign Agricultural Service. Chinese hemp is mainly used in cosmetics but also in electronic cigarettes, medicines and animal feed.

PROHIBITION OF CANNABIS-DERIVED INGREDIENTS IN CHINA

On March 26, China’s National Institute for Food and Drug Control (NIFDC) has presented a proposal to ban some cannabis-derived ingredients in cosmetic and personal care products. Cannabis sativa leaf extract Cannabis sativa seed oil, Cannabis sativa fruit and Cannabidiol (CBD) are some of the ingredients proposed to be prohibited. A public consultation was opened and stakeholders could send comments to the NFDC (by email) until April 19 (2021) in order to allow the government to make the appropriate decision.

Last month (May 28th), the National Medical Products Administration (NMPA) released and implemented the finalized Inventory of Prohibited Ingredients for Cosmetics and Inventory of Prohibited Plant (Animal) Ingredients for Cosmetics. 24 new prohibited cosmetic ingredients were added to these inventories. Among them were Cannabidiol and 3 other Cannabis Sativa-derived ingredients, which are now prohibited from being produced and imported in China.

This new legislation is controversial, especially because an ordinance, published in 2015, allowed the use of these cannabis-derived ingredients (CBD from hemp and products containing less than 0.3% THC) in cosmetic products available in the Chinese market.

In one of our previous posts, we have already discussed the increasing importance of cannabis-derived ingredients in cosmetic and personal care products. In the last few years these compounds have been increasingly used in cosmetics, not only in China, but also around the globe. These ingredients have shown beneficial effects on the skin, like hydration and helping on inflammation reduction. The use of skincare and beauty products containing CBD has become a major beauty trend.

The ban of these ingredients will have repercussions at national level, but also at international level. These compounds are highly sought after and allowed in other markets like the European Union (EU). Exports and e-commerce will be strongly affected.

Other countries are approving the use of cannabis ingredients in cosmetics. Thailand is one of those countries. January this year, Thailand officially legalized the use of 9 low-THC cannabis and hemp ingredients in cosmetics. Usage restrictions and labelling requirements were laid down in two business guidelines in order to regulate the use of these ingredients. For example, cosmetics produced domestically may contain the cannabis-based allowed ingredients but cosmetics containing these ingredients can not be imported.

In sum, although China government allows the cultivation of hemp, it criminalizes its possession. The ban of cannabis-derived ingredients in cosmetics will have strong consequences on the beauty market, making exportation and selling online cosmetics containing these compounds prohibited.

References:

  1. Breaking News! China to Ban CBD and 3 Other Cannabis sativa Derived Ingredients in Cosmetics. Chemlinked. Available from: https://cosmetic.chemlinked.com/news/cosmetic-news/breaking-china-to-ban-cbd-and-other-3-cannabis-sativa-derived-ingredients-in-cosmetics
  2. CBD will be Banned in China. CosmeticsBridge Asia-Pacific. Available from: https://www.cosmeticsbridge.com/cbd-will-be-banned-in-china/

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »